We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
-5.47%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$3.08B
AUM Growth
-$6.76M
Cap. Flow
+$105M
Cap. Flow %
3.4%
Top 10 Hldgs %
15.03%
Holding
2,640
New
753
Increased
593
Reduced
560
Closed
711

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$64.6M
2
IQ icon
iQIYI
IQ
+$35.6M
3
FUTU icon
Futu Holdings
FUTU
+$31.5M
4
QFIN icon
Qfin Holdings
QFIN
+$27.8M
5
TCOM icon
Trip.com Group
TCOM
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 9.64%
2 Consumer Discretionary 7.81%
3 Healthcare 5.12%
4 Financials 3.9%
5 Communication Services 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
1901
Immunic
IMUX
$193M
$1K ﹤0.01%
+12
New +$1.18K
PRDO icon
1902
Perdoceo Education
PRDO
$2.06B
$1K ﹤0.01%
+134
New +$1.51K
SPTN
1903
DELISTED
SpartanNash
SPTN
$1K ﹤0.01%
+39
New +$785
UFI icon
1904
UNIFI
UFI
$133M
$1K ﹤0.01%
25
-551
-96% -$12.5K
ACHL
1905
DELISTED
Achilles Therapeutics
ACHL
$1K ﹤0.01%
+98
New +$645
MODN
1906
DELISTED
MODEL N, INC.
MODN
$1K ﹤0.01%
+33
New +$1.11K
VIEW
1907
DELISTED
View, Inc. Class A Common Stock
VIEW
$1K ﹤0.01%
+2
New +$702
DSKE
1908
DELISTED
Daseke, Inc. Common Stock
DSKE
$1K ﹤0.01%
+87
New +$724
ELVT
1909
DELISTED
Elevate Credit, Inc.
ELVT
$1K ﹤0.01%
+203
New +$729
PHAS
1910
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$1K ﹤0.01%
164
RVI
1911
DELISTED
Retail Value Inc. Common Shares
RVI
$1K ﹤0.01%
392
-7,681
-95% -$17.4K
AAPL icon
1912
PUT
Apple
AAPL
$4.47T
-17,100
Closed -$2.34M
ABM icon
1913
ABM Industries
ABM
$2.83B
-5,609
Closed -$249K
ACGL icon
1914
Arch Capital
ACGL
$33.4B
-7,134
Closed -$278K
ACET icon
1915
Adicet Bio
ACET
$75.5M
-108
Closed -$18K
ACHC icon
1916
Acadia Healthcare
ACHC
$2.95B
-4,932
Closed -$309K
ACIW icon
1917
ACI Worldwide
ACIW
$5.26B
-286
Closed -$11K
ACLS icon
1918
Axcelis
ACLS
$4.15B
-1,409
Closed -$57K
ACRS icon
1919
Aclaris Therapeutics
ACRS
$844M
-2,378
Closed -$42K
ADCT icon
1920
ADC Therapeutics
ADCT
$142M
$0 ﹤0.01%
2
ADN
1921
DELISTED
Advent Technologies
ADN
-331
Closed -$96K
ADPT icon
1922
Adaptive Biotechnologies
ADPT
$4.1B
-267
Closed -$11K
ADV icon
1923
Advantage Solutions
ADV
$361M
-22
Closed -$6K
AEIS icon
1924
Advanced Energy
AEIS
$13B
-1,767
Closed -$199K
AEO icon
1925
American Eagle Outfitters
AEO
$3.04B
-2,172
Closed -$82K

Similar funds

Point72 Hong Kong's Q3 2021 Portfolio in Review

As of Q3 2021, Point72 Hong Kong held 2,640 positions worth $3.08B, down 0.22% from $3.08B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Point72 Hong Kong deployed $105M of net new capital in Q3 2021, opening 753 new positions and adding to 593 existing holdings. Its largest new stake was TAL Education Group: 7,640,923 shares worth $37M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Trip.com Group, an estimated $22.4M trimmed.

  • Point72 Hong Kong's largest Q3 2021 buy was TAL Education Group: 7,640,923 shares worth $37M.
  • Point72 Hong Kong added most to Huazhu Hotels Group in Q3 2021, an estimated $23.8M increase.
  • Point72 Hong Kong's biggest Q3 2021 reduction was Trip.com Group, cutting an estimated $22.4M.
  • Point72 Hong Kong fully exited Nike in Q3 2021, selling an estimated $64.6M.
  • Point72 Hong Kong's ten largest holdings make up 15% of its $3.08B portfolio in Q3 2021.
  • Point72 Hong Kong opened 753 new positions and closed 711 in Q3 2021.
  • Point72 Hong Kong's portfolio value fell 0.22% quarter-over-quarter to $3.08B.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.